Jump to main content
Jump to site search

Issue 31, 2016
Previous Article Next Article

Horner–Wadsworth–Emmons approach to piperlongumine analogues with potent anti-cancer activity

Author affiliations

Abstract

Natural products with anti-cancer activity play a vital role in lead and target discovery. We report here the synthesis and biological evaluation of the plant-derived alkaloid, piperlongumine and analogues. Using a Horner–Wadsworth–Emmons coupling approach, a selection of piperlongumine-like compounds were prepared in good overall yield from a novel phosphonoacetamide reagent. A number of the compounds displayed potent anti-cancer activity against colorectal (HCT 116) and ovarian (IGROV-1) carcinoma cell lines, via a mechanism of action which may involve ROS generation. Contrary to previous reports, no selective action in cancer cell (MRC-5) was observed for piperlongumine analogues.

Graphical abstract: Horner–Wadsworth–Emmons approach to piperlongumine analogues with potent anti-cancer activity

Back to tab navigation

Supplementary files

Publication details

The article was received on 27 May 2016, accepted on 15 Jul 2016 and first published on 22 Jul 2016


Article type: Paper
DOI: 10.1039/C6OB01160H
Citation: Org. Biomol. Chem., 2016,14, 7585-7593
  •   Request permissions

    Horner–Wadsworth–Emmons approach to piperlongumine analogues with potent anti-cancer activity

    L. Han, P. A. Stanley, P. J. Wood, P. Sharma, A. I. Kuruppu, T. D. Bradshaw and J. E. Moses, Org. Biomol. Chem., 2016, 14, 7585
    DOI: 10.1039/C6OB01160H

Search articles by author

Spotlight

Advertisements